Nurse Practitioner · Atherton, CA
NPI
1225295694
Since 2008
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3351 El Camino Real, Ste 200
Atherton, CA, 94027
Phone (650) 399-4630
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$576K
1,089 prescriptions
Company payments, 2025
$893
From 7 companies
Medicare prescription drug claims, 2024
In 2024, the drug Kathleen M Low prescribed most often to Medicare patients was Montelukast Sodium, with 120 prescriptions and refills. In total Kathleen M Low wrote 1,089 Medicare prescriptions that cost $576K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Montelukast Sodium Generic | 120 | 323 | 42 | $1,636 |
| Ipratropium Bromide Generic | 116 | 189 | 44 | $4,189 |
| Azelastine Hcl Generic | 103 | 233 | 52 | $3,832 |
| Dupixent Pen Dupilumab | 64 | 74 | Under 11 | $280K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 59 | 59 | 41 | $658 |
| Methylprednisolone Generic | 58 | 58 | 47 | $470 |
| Mupirocin Generic | 51 | 55 | 26 | $737 |
| Doxycycline Hyclate Generic | 49 | 49 | 41 | $619 |
| Prednisone Generic | 43 | 43 | 34 | $284 |
| Dupixent Syringe Dupilumab | 40 | 44 | Under 11 | $170K |
| Ciprofloxacin Hcl Generic | 40 | 45 | 19 | $934 |
| Xhance Fluticasone Propionate | 35 | 76 | 15 | $78K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 27 | 27 | 17 | $101 |
| Azithromycin Generic | 26 | 32 | 17 | $290 |
| Fluticasone Propionate Generic | 23 | 52 | 14 | $487 |
Brand drugs: - claims; generic drugs: 879 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathleen M Low $893 ($893 in general payments such as food, travel and fees) from 7 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $295.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.